Microvast Holdings announces departure of chief financial officer
Investing.com - Sanara Medtech reported on Monday third quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Sanara Medtech announced earnings per share of $-0.32 on revenue of $13M. Analysts polled by Investing.com EPS of $-0.32 on revenue of $14.7M.
Sanara Medtech 's are up 14% and is trading at $34.72 , still down 2.72% from its 52 week high of $35.69 set on Monday, November 14, 2022.
Sanara Medtech follows other major Healthcare sector earnings this month
Sanara Medtech's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar